Evidence map›Paper›PMID 42728540›Full record

ReviewStem cell reviews and reports2026

Current Translational 3D In Vitro Models of Human Placental Tissue.

Ananya Raman, Niamh E P Mills, Louise Cole, Claire Richards, Lana McClements

Abstract readReview
PubMed Publisher
In one paragraph

Review in Stem cell reviews and reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ananya RamanSchool of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0009-0009-1709-326X
Niamh E P MillsSchool of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0009-0004-8076-1666
Louise ColeSchool of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-9206-9272
Claire RichardsSchool of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia. claire.richards@uts.edu.au.ORCID http://orcid.org/0000-0001-5080-9164
Lana McClementsSchool of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia. lana.mcclements@uts.edu.au.ORCID http://orcid.org/0000-0002-4911-1014

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular models of placental tissue have the potential to recapitulate normal physiology, model disease, and facilitate therapeutic drug testing. In vivo or two-dimensional (2D) in vitro models of placental conditions have not been sufficiently representative of whole human tissue, thus have limited physiological relevance. This can be attributed to interspecies differences in placental physiology or a lack of structural complexity. In comparison, three-dimensional (3D) multicellular model systems provide a more sophisticated analogue of human placental tissue. Newer models of human placenta include 3D organoids, placenta-on-a-chip and organoid-on-a-chip, employing a range of materials and methods including pluripotent or trophoblast stem cells, microfluidics and 3D bioprinting. Accurately mimicking in vivo human tissue is crucial to the success of these translational 3D models of the placenta.In turn, a reliable representation of placental tissue architecture will allow discovery of the mechanisms underlying abnormal placental development and inform the prevention, diagnosis and treatment of pregnancy-related disorders such as preeclampsia and fetal growth restriction. Here, we provide a comprehensive critical appraisal of recent advances in 3D placental models, which aim to elucidate placental physiology, development and dysfunction. Additionally, we discuss how these platforms can accelerate the development of better monitoring and treatment strategies for pregnancy complications induced by a dysfunctional placenta.

Indexed as

BioprintingOrganoidsPlacentaPlacenta-on-a-chipPregnancyTrophoblast cells

Identifiers

PMID42728540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.